Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EncorVita is a specialized service provider and consultancy focused on the cell and gene therapy (CGT) industry. Founded by industry veteran Robert Preti, the company provides end-to-end solutions for the development, manufacturing, and commercialization of advanced medicinal products. EncorVita's expertise spans the "vein-to-vein" supply chain, offering strategic guidance and operational support to biotech companies navigating the complexities of CGT production. The company aims to accelerate the delivery of life-saving therapies by optimizing manufacturing processes and regulatory pathways. Their services include facility design, technical operations, and quality systems management tailored for regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EncorVita Health.